The nuclear localization of low risk HPV11 E7 protein mediated by its zinc binding domain is independent of nuclear import receptors

Virology

Volumn 407, Issue 1, 2010, Pages 100-109

  Piccioli, Zachary ^a   McKee, Courtney H ^a   Leszczynski, Anna ^a   Onder, Zeynep ^a   Hannah, Erin C ^a   Mamoor, Shahan ^a   Crosby, Lauren ^a   Moroianu, Junona ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

FG nucleoporins; Human papillomavirus; Low risk HPV11 E7 protein; Nuclear import pathway; Nuclear localization signal; Zinc binding domain

Indexed keywords

DIGITONIN; ENHANCED GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROTEIN E7; RAN PROTEIN; ZINC BINDING PROTEIN; E7 PROTEIN, HUMAN PAPILLOMAVIRUS 11; GREEN FLUORESCENT PROTEIN; ONCOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELL NUCLEUS; CELL PERMEABILIZATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; INFECTION RISK; INTRACELLULAR SIGNALING; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; ACTIVE TRANSPORT; BINDING SITE; CHEMISTRY; GENE FUSION; GENETIC TRANSFECTION; HELA CELL LINE; METABOLISM; PHYSIOLOGY; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; REPORTER GENE; SITE DIRECTED MUTAGENESIS; VIRUS REPLICATION;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID MOTIFS; ARTIFICIAL GENE FUSION; BINDING SITES; CELL NUCLEUS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMAN PAPILLOMAVIRUS 11; HUMANS; MUTAGENESIS, SITE-DIRECTED; ONCOGENE PROTEINS, VIRAL; PROTEIN STRUCTURE, TERTIARY; RAN GTP-BINDING PROTEIN; TRANSFECTION; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS;

EID: 77956937842     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.07.045     Document Type: Article

References (25)

1. Angeline M., Merle E., Moroianu J. The E7 oncoprotein of high-risk human papillomavirus type 16 enters the nucleus via a nonclassical Ran-dependent pathway. Virology 2003, 317(1):13-23.
2. Baldwin A., Huh K.W., Munger K. Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function. J. Virol. 2006, 80(13):6669-6677.
3. Bonifaci N., Moroianu J., Radu A., Blobel G. Karyopherin beta2 mediates nuclear import of a mRNA binding protein. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(10):5055-5060.
4. Chook Y.M., Blobel G. Structure of the nuclear transport complex karyopherin-beta2-Ran x GppNHp. Nature 1999, 399(6733):230-237. [see comments].
5. Clemens K.E., Brent R., Gyuris J., Munger K. Dimerization of the human papillomavirus E7 oncoprotein in vivo. Virology 1995, 214(1):289-293.
6. Coutavas E., Ren M., Oppenheim J.D., D'Eustachio P., Rush M.G. Characterization of proteins that interact with the cell-cycle regulatory protein Ran/TC4. Nature 1993, 366(6455):585-587.
7. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. (Lond.) 2006, 110(5):525-541.
8. Floer M., Blobel G. The nuclear transport factor karyopherin beta binds stoichiometrically to Ran-GTP and inhibits the Ran GTPase activating protein. J. Biol. Chem. 1996, 271(10):5313-5316.
9. Genovese N.J., Banerjee N.S., Broker T.R., Chow L.T. Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes. J. Virol. 2008, 82(10):4862-4873.
10. Guccione E., Massimi P., Bernat A., Banks L. Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins. Virology 2002, 293(1):20-25.
11. Huh K.W., DeMasi J., Ogawa H., Nakatani Y., Howley P.M., Munger K. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(32):11492-11497.
12. Knapp A.A., McManus P.M., Bockstall K., Moroianu J. Identification of the nuclear localization and export signals of high risk HPV16 E7 oncoprotein. Virology 2009, 383(1):60-68.
13. Liu X., Clements A., Zhao K., Marmorstein R. Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J. Biol. Chem. 2006, 281(1):578-586.
14. Lounsbury K.M., Richards S.A., Carey K.L., Macara I.G. Mutations within the Ran/TC4 GTPase. Effects on regulatory factor interactions and subcellular localization. J. Biol. Chem. 1996, 271(51):32834-32841.
15. McIntyre M.C., Frattini M.G., Grossman S.R., Laimins L.A. Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding. J. Virol. 1993, 67(6):3142-3150.
16. McLaughlin-Drubin M.E., Munger K. The human papillomavirus E7 oncoprotein. Virology 2009, 384(2):335-344.
17. Moroianu J., Blobel G., Radu A. Previously identified protein of uncertain function is karyopherin alpha and together with karyopherin beta docks import substrate at nuclear pore complexes. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(6):2008-2011.
18. Naim B., Zbaida D., Dagan S., Kapon R., Reich Z. Cargo surface hydrophobicity is sufficient to overcome the nuclear pore complex selectivity barrier. EMBO J. 2009, 28(18):2697-2705.
19. Nelson L.M., Rose R.C., Moroianu J. Nuclear import strategies of high risk HPV16 L1 major capsid protein. J. Biol. Chem. 2002, 23:23.
20. Nguyen C.L., Munger K. Human papillomavirus E7 protein deregulates mitosis via an association with nuclear mitotic apparatus protein 1. J. Virol. 2009, 83(4):1700-1707.
21. Ohlenschlager O., Seiboth T., Zengerling H., Briese L., Marchanka A., Ramachandran R., Baum M., Korbas M., Meyer-Klaucke W., Durst M., Gorlach M. Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7. Oncogene 2006, 25(44):5953-5959.
22. Ribbeck K., Gorlich D. The permeability barrier of nuclear pore complexes appears to operate via hydrophobic exclusion. EMBO J. 2002, 21(11):2664-2671.
23. Tsuji T., Sheehy N., Gautier V.W., Hayakawa H., Sawa H., Hall W.W. The nuclear import of the human T lymphotropic virus type I (HTLV-1) tax protein is carrier- and energy-independent. J. Biol. Chem. 2007, 282(18):13875-13883.
24. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 2000, 92(9):690-698.
25. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009, 384(2):260-265.